News
Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial
Summary by The San Francisco Editorial Desk ABCNews , as published by ABC7 News (KGO-TV, ABC)
· August 19, 2026
· 1 min read
Photo: ABC7 News (KGO-TV, ABC) · view original
Story provenance No corrections
Summary created by The San Francisco Editorial Desk — automated, rule-governed Byline on source page ABCNews, as published by ABC7 News (KGO-TV, ABC) Original story Read at the source Source published Aug 19, 2026 Indexed here Aug 19, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log · Publisher’s note
Key points The vaccine's success was announced on Wednesday, marking a significant development in cancer treatment. Merck and Moderna announced the success of this vaccine in a large, late-stage trial.
A personalized mRNA-based cancer vaccine has shown promise in extending life span. Merck and Moderna announced the success of this vaccine in a large, late-stage trial. The trial involved high-risk patients with melanoma.
The vaccine's success was announced on Wednesday, marking a significant development in cancer treatment. Further details about the trial and its outcomes are available from the source.
More information can be found from Merck and Moderna's announcement, which provides insight into the vaccine's potential in treating melanoma.
More News Today’s briefing Local events
Why this story is here
ABC7 News (KGO-TV, ABC) reported and published this story. The San Francisco selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by ABC7 News (KGO-TV, ABC) . The San Francisco selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit ABC7 News (KGO-TV, ABC) . Have a tip or correction? Contact the editor .
Category: News Published: August 19, 2026 Source: ABC7 News (KGO-TV, ABC) Reading time: 1 min
Frequently asked about this story
What is this story about? A personalized mRNA-based cancer vaccine has shown promise in extending life span. Merck and Moderna announced the success of this vaccine in a large, late-stage trial. The trial involved high-risk…
When was this published? This article was first published on August 19, 2026 by ABC7 News (KGO-TV, ABC) and curated for The San Francisco readers.
Who reported this story? This story was reported by ABCNews at ABC7 News (KGO-TV, ABC). To learn more about how The San Francisco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The San Francisco, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
